Which Indian neighbouring nation rejected the Chinese Corona vaccine co-financing request and why!
By Sharonya Kundu
The clinical study of an experimental Chinese Coronavirus vaccine developed by Sinovac Biotech in Bangladesh is now unsettled as the health minister rejected co-financing the launch as requested by the Chinese pharmacist.
Health Minister Zahid Maleque has said that co-financing was not mentioned in the agreement and therefore the company never demanded money once they approached the Bangladesh government. Sinovac had agreed to take care of all the expenses and provide 1.10 lakh free vaccines to the country. They had also agreed to share the technology with Bangladesh pharmaceutical companies to form the vaccine. Bangladesh is already talking to at least five frontrunners for the vaccine including AstraZeneca.
The Chinese company Sinovac Biotech had initially put up the manifesto for phase 3 trial of the Coronavirus vaccine to Bangladesh through the Dhaka based International Centre for Diarrhoeal Disease Research, Bangladesh. The government allowed final clearance for the clinical trial on 27th August. The appeal for co-financing was made later by the Chinese vaccine company earlier this month. According to sources, it is accumulated that around 60 crore was the spending on conducting the trial on 4,200 volunteers. Bangladesh will get the Sinovac vaccine, even if the case does not go ahead as outlined.